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Abstract
Background: The status characterized by the imbalance between pro-oxidants and antioxidants molecules, defined
as oxidative stress, has been suggested to be involved in the pathogenesis of subfertility in females. This study aims
to evaluate the impact of a complete micronutrients supplementation on oxidative stress levels in follicular
microenvironment as well as on in vitro fertilization (IVF) outcome.
Methods: This preliminary study was conducted between January 2014 and July 2015 at the Siena University
Hospital Infertility Clinic. Serum and follicular fluid were collected from infertile women aged > 39 years who
underwent two in vitro fertilization cycles: in the first cycle they were treated with GnRH-antagonist protocol and
gonadotropins for controlled ovarian hyperstimulation, whereas in the second cycle ovarian stimulation protocol
was associated to micronutrients supplementation, starting three months earlier. Protein oxidation levels and
total antioxidant capacity in serum and in follicular fluid were evaluated in IVF cycles with or without micronutrients
supplementation. Differences in IVF outcome parameters were statistically evaluated.
Results: Two-dimensional electrophoresis analyses demonstrated that when patients assumed micronutrients before
IVF cycles, follicular fluid and serum proteins were protected from oxidative damage. Comparable results were
obtained when total antioxidant capacity was measured. Moreover, the mean number of good quality oocytes
retrieved when patients received micronutrients supplementation was significantly increased.
Conclusion: The additional treatment with micronutrients, starting three months before IVF cycles, protects the
follicular microenvironment from oxidative stress, thus increasing the number of good quality oocytes recovered
at the pick up.
Keywords: Micronutrients, In vitro fertilization, Follicular fluid, Oxidative stress, Oocyte quality
Abbreviations: FF, Follicular fluid; GnRH, Gonadotropin-releasing hormone; hCG, Human chorionic gonadotropin;
ICSI, Intra-cytoplasmic sperm injection; IVF, In vitro fertilization; OS, Oxidative stress; ROS, Reactive oxygen species;
VDR/RXR-α, Vitamin D receptor and retinoid X receptor-alpha heterodimer
Background
Recent studies on the pathophysiology of couple’s infer-
tility have shown that oxidative stress (OS) may be one
of the causative factors of female infertility [1–3]. The
OS is currently defined as an increase in the level of re-
active oxygen species (ROS) due to the decreased
antioxidant capacity of the cells to scavenge and remove
these free radicals [4]. The oxidizing species are prod-
ucts of normal metabolic activity that, at physiological
concentration, play pivotal roles both at cellular and sys-
temic level. Numerous protective mechanisms that pre-
vent the formation of reactive species, or their removal
before they can damage cell components, have been
identified [5]. Indeed, the impairment of this physio-
logical balance between ROS production andelimination,
may result in the alteration of cellular structures and
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macromolecules ultimately leading to cell death [6]. The
main targets of ROS are lipids, nucleic acids, carbohy-
drates and proteins [7]. Oxidative reactions may com-
pletely alter physical/chemical properties of proteins by
proteolysis, structural modifications, aberrant combina-
tions, oxidation of the side chains of amino acids [8]. In
fact, the oxidation of the -R groups of amino acids, cause
the variation of the isoelectric point, whereas the forma-
tion of intramolecular bonds and/or protein cleavage
into peptide fragments induces alteration of the molecu-
lar weight [9–12]. Moreover, proteins having in their
backbone cysteine and methionine, sulfur-containing
amino acids, are more susceptible to the attack of ROS,
since thiols may undergo reversible oxidization [11, 13].
It appears that oxidative stress plays an essential
physiological role in the modulation of a full spectrum
of reproductive functions, such as oocyte maturation,
ovarian steroidogenesis, formation of the corpus luteum
and luteolysis, fertilization, embryo development and
pregnancy [2, 4, 14]. The impact of OS on the repro-
ductive potential has been investigated by several
studies focused on the microenvironment surrounding
the oocyte [15–20]; all these study clearly highlighted
that there is a complex relationship between ROS and
antioxidants in the ovary. In particular, oxidative
damage has been implicated as a causal factor in the
oocytes quality. The failure of antioxidant defense
mechanisms to neutralize OS, allows free radicals to
alter the cellular redox state, with decreased total
antioxidant capacity in follicles accompanied by poor
oocyte fertilization [1, 16, 21, 22].
Numerous protective substance that counteract the
formation of reactive species, have been hitherto identi-
fied [23, 24] and numerous commercial preparations
containing antioxidant micronutrients have been devel-
oped. Among the others, the particular micronutrients
supplement, we assessed in this study, represents a suit-
able preparation for its broad composition, including vi-
tamins, folates and minerals. Vitamin E and A have been
reported as potent non-enzymatic antioxidants that play
a significant role in protecting the integrity of the cell
membrane and in promoting reproductive function. In
humans it has been shown that vitamin E reacts with
free radicals transforming them in hydroperoxides, sub-
stance safely metabolized by the cell; in addition, vitamin
E interacts and neutralizes three important ROS, e.g.
superoxide anion, hydrogen peroxide and the hydroxyl
radical [23]. Finally, vitamin E is also able to interrupt
the process of lipid peroxidation acting as a chain-
breaking antioxidant.
It has been demonstrated that Vitamin A and caroten-
oids are able to protect the cells from superoxide radi-
cals and, most importantly, a decrease in their serum
concentration has been associated with anovulation [25].
Also folate has been reported as effective antioxidants,
so that women receiving folic acid supplementation had
a better quality oocytes and a higher degree of mature
oocytes compared with women who did not receive folic
acid supplementation [26].
Based on these observations, this study aimed to
evaluate the effectiveness of a complete micronutri-
ents supplementation on the level of oxidative stress,
both in serum and in follicular fluid (FF), of infertile




The study was approved by Ethic Committees of Siena
University. Signed informed consent was obtained from
all patients who participated in the study, performed at
the Center for Couple Sterility, Siena University Hos-
pital, between January 2014 and July 2015. A total of 18
patients aged >39 years undergoing IVF/ICSI treatment
were included in the study. All patients have been un-
able to conceive naturally for at least 1 year before enter-
ing the study. The reasons for the couples’ infertility
were male factor infertility (n = 8), polycystic ovary syn-
drome (n = 6), tubal occlusion (n = 3) and endometriosis
(n = 1). The physical and demographic characteristics of
all recruited women are shown in Table 1. All patients
underwent two IVF cycles within a period of 9–12
months: in the first cycle they were treated with gonado-
tropins for ovulation induction, while in the second
cycle gonadotropin treatment was associated to micro-
nutrients supplementation (Elevit, Bayer; 1 cp/day),
starting three months earlier.
Ovulation induction
Ovarian stimulation was performed administering re-
combinant gonadotropins (Pergoveris, Merck-Serono,
Rome, Italy) at a dose of 150–300 IU per day from the
1nd or 2rd day of spontaneous or induced menstruation.
The dose of gonadotropins was adjusted according to
ovarian response, as detected by ultrasound examination.
Table 1 Characteristics of patients who underwent the two IVF
cycles, without (untreated) and with (treated) micronutrients
supplementation
Variable Untreated Treated P value
No. of patients 18 —
Age (yrs) 40.3 ± 1.2 —
Duration of infertility (months) 26.1 ± 8.2 —
Body mass index (kg/m2) 22.5 ± 3.0 —
Duration of stimulation (days) 11.5 ± 0.9 12.1 ± 1.4 NS
E2 peak level 2,315 ± 490 2,270 ± 515 NS
Note: Values are mean ± SD. NS not significant
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As soon as the dominant follicle reached 14 mm in diam-
eter, a gonadotropin-releasing hormone (GnRH) antagon-
ist was administered daily, until the day of ovulation
triggering which was obtained by HCG injection, when at
least three follicles of size >18 mm were present in the
ovaries. The oocyte pick-up was performed 34–36 h after
the human chorionic gonadotropin (hCG) injection. Fol-
licular fluid was aspirated and after collecting the oocytes
the fluid was centrifuged for 10 min at 1500 rpm. Only
follicular fluid samples with no macroscopic evidence
of blood were selected. For each patient, at the day
of oocyte pickup, blood serum samples for compara-
tive analysis was collected.
Oocyte morphology
Oocyte morphology was evaluated according to previ-
ously published criteria [27]. Dimorphisms were sub-
divided into intracytoplasmic and extracytoplasmic. In
the first case we evaluated the presence of incorpora-
tions, refractile bodies, vacuoles, aggregation of the
smooth endoplasmatic reticulum and dense granula-
tion. The assessment of extracytoplasmic dimorphism
was based on the first polar body morphology, peri-
vitelline space size and granularity, zona pellucida
defects and shape anomalies. We considered high
quality oocytes those cells without any of the previ-
ously described alterations. The evaluation was carried
out by two different embryologists, blinded to the
study protocol.
The FRAP assay
The total antioxidant capacity (TAC) was measured as
ferric-reducing ability of follicular fluid and serum
(FRAP), according to Benzie and Strain [28], by spectro-
photometric quantification. Briefly, working FRAP re-
agent was prepared by combining in the ratio of 10:1:1 a
300 mM acetate buffer pH3.6, 10 mM 2,4,6‐tri‐(2‐pyri-
dyl)‐1,3,5‐triazine, in 40 mM HCl and 20 mM FeCl3.
A 50 μl aliquot of follicular fluid or serum was added
to 1 ml of FRAP reagent and 10 min later the absorb-
ance measurement was taken at 593 nm. As standard
reference, 50 μl of the standard (FeSO4 1 mM) was
added to 1 ml of FRAP reagent. All measurements
were taken at room temperature with samples pro-
tected from direct sunlight.
Follicular fluid and blood serum proteins analysis
Free –SH groups labeling with MPB
This assay was carried out according to a modified proto-
col as described by de Lamirande and Gagnon [29]. A
solution of 3-N-maleimidopropionyl biocytin (MPB;
Sigma Aldrich, St Louis, MO, USA) 1 mM in Tris-HCl
15 mM pH 6.8 was added to equivalent amount of FF pro-
teins, in a final volume of 100 μl. Protein concentration
was determined by Bicinchoninic Acid Kit (Sigma-Aldrich,
St Louis, MO, USA) following the manufacturer’s instruc-
tion. The mixture was then heated at 95 °C for 5 min and
immediately processed for 2D electrophoresis.
Two-dimensional electrophoresis
Two-dimensional (2D) electrophoresis was carried out
as described: 30 μg of total protein were resuspended in
rehydration solution and mixed with 0.2 % immobilized
pH gradient buffer (IPG, GE Healthcare, Uppsala,
Sweden) with a 3–11 nonlinear pH range. Samples were
loaded onto Immobiline DryStrips with immobilized
nonlinear pH gradient, ranging from pH 3 to 11 (GE
Healthcare). Isoelectric focusing was performed as de-
scribed by Görg et al. [30] and Bjellqvist et al. [31]. Iso-
electric focused strips were equilibrated for 15 min with
50 mM Tris-HCl pH 6.8 containing 30 % glycerol, 6 M
urea, and 2 % sodium dodecyl sulfate (SDS) and for an
additional 5 min in the same solution containing 2.5 %
iodoacetamide (IAA) and 0.1 % bromophenol blue, and
then placed on a 6–16 % polyacrylamide linear gradient
SDS gel according to Laemmli et al. [32].
Western blotting
For western blotting analysis, proteins were electro-
blotted from polyacrylamide gels to nitrocellulose ac-
cording to Towbin et al. [33]. Membranes were then
incubated with streptavidin conjugated to peroxidase in
TBS containing 0.2 % Tween 20, with 1 % non-fat dry
milk. Reactivity was detected using an Immuno-Star
HRP Chemiluminescent kit (Bio-Rad Microsciences) and
revealed with an XRS instrument ChemiDoc (Bio-Rad
Microsciences, Hemel Hempstead, UK). Images were
then processed using the Quantity One® 4.5.7 and
PDQuestTM 7.4.0 softwares (Bio-Rad Microsciences) for
spots identification and quantification as pixel/mm2.
Statistical analysis
Statistical analysis was performed with the software
Graph pad Prism 4 (GraphPad Software, San Diego,
CA, USA). The standardized values of skewness and
kurtosis will be used to verify the normal distribution
of data. Parametric or non-parametric tests were used
when appropriate. Statistical significance will be set at
a value of P <0.05.
Results
Demographic features and clinical data of patients are
presented in Table 1. Total FSH-LH units, number of
days of stimulation, peak E2 levels at hCG administra-
tion were not significantly different between the two IVF
cycles (without or with micronutrients supplementation)
in the enrolled patients. In order to detect the oxidative
stress levels, we measured the total antioxidant capacity
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and ROS induced-damage on proteins both in follicular
fluid and in serum. By means of the FRAP assay we
measured total antioxidant capacity showing a signifi-
cant increase in TAC both in follicular fluid and in
serum of women treated with micronutrient supplemen-
tation (Fig. 1). In order to confirm these data, we ana-
lyzed all samples by two dimensional electrophoresis to
monitor the presence of free-SH residues in serum and
follicular fluid proteins. In Fig. 2, a representative 2D-
electroforesis of serum and follicular fluid proteins is
showed. By this procedure, numerous spots distributed
in a pH range of about 4–7 with an apparent molecular
weight ranging between 15 and 75 kDa (Fig. 2a and c)
were evident in patients not receiving micronutrient
supplementation (untreated) during the first IVF cycle.
When the same analysis was performed in patients re-
ceiving a micronutrient supplementation in the second
IVF cycle, starting from three months before controlled
ovarian stimulation, we observed an increased number
of proteins with free thiol groups (Fig. 2b and d). There-
fore, a significant recovery of a physiological level in the
overall oxidative stress status in these biological fluids
after treatment is demonstrated. Indeed, both in blood
serum and follicular fluid of treated women, 2D electro-
phoresis detected numerous spots distributed between
pH 4 and 7, with a wide molecular weight ranging from
about 60 to 200 kDa (Fig. 2b and d). The quantitative
analysis of main spots enabled us to highlight a statisti-
cally significant increase in spot intensity in both serum
and follicular fluid recovered from women treated with
micronutrient supplementation (p < 0.05) in comparison
to untreated (Fig. 2). As regard to IVF outcome parame-
ters, we observed that the mean number of retrieved
oocytes did not differ between the two cycles, whereas
the mean number of oocytes not suitable for injection
was significantly reduced (1.20 ± 0.77 vs. 1.88 ± 1.01; P =
0.01) in the micronutrients supplemented cycles.
Fertilization and cleavage rates as well as the mean num-
ber of top-quality transferred embryos did not differ sig-
nificantly (Table 2). Nevertheless, in the treated group,
we registered a total of 3 ongoing pregnancies (preg-
nancy rate =17.7 %), which represent an encouraging re-
sults in aged women undergoing to IVF.
Discussion
Data from this study suggest that patients assuming
micronutrients before IVF cycles have a high level of
free-SH groups in follicular fluid and serum proteins, in-
dicating a protective activity from oxidative damages by
this supplementation.
The oxidative stress and the ROS level in biological
fluid may be indirectly measured by a proteomic ap-
proach, that allow the accurate evaluation of oxidative
stress induced-damage on proteins [34, 35]. The main
target of free radicals are proteins that undergo to oxida-
tion of the side chains of amino acids [9, 12] where cyst-
eine and methionine are key components in the
mechanism involved in redox balance, since thiols group
(−SH) may be oxidized in an almost irreversible manner
[13, 36, 37]. Indeed, an inverse correlation between
levels of free-SH group in proteins from biological fluids
and oxidative stress may be established. By this way, we
showed in both serum and follicular fluid a dramatic in-
crease in the level of protein free -SH groups in women
treated with a micronutrients supplementation, suggest-
ing a significant decrease of the oxidative stress in the
follicular microenvironment. In this study, we confirmed
the efficacy of micronutrient supplementation also by
means of FRAP, a sensitive and reproducible approach
commonly used to monitor total antioxidant capacity in
biological fluid. This strong correlation is very important
since confirm our proteomic strategy as an excellent ap-
proach to study ROS levels in biological sample. It
should be outlined that the direct evaluation of the oxi-
dative stress levels in biological fluids is very difficult be-
cause the cellular elements that produce them are
absent, and because the radical species are generated
and dissolve continuously. The demonstrated close rela-
tion between FRAP results and protein free -SH groups
in biological samples will allow the researchers to specif-
ically evaluate the effect of ROS by indirectly measuring
the protein damage levels.
The supplementation seems to be effective not only in
diminishing oxidative stress, but also in increasing oo-
cyte quality; in fact, a significant decrease in the mean
number of oocytes not suitable for injection could be
observed. Our data confirmed numerous publications
Fig. 1 Total antioxidant capacity in follicular fluid and in serum from
untreated patient (white bars) or patient treated with micronutrients
supplementation (gray bars). The values are the mean of three
determinations ± SD. Statistically significant difference in total
antioxidant capacity is indicated (*P < 0.05)
Luddi et al. Reproductive Biology and Endocrinology  (2016) 14:57 Page 4 of 7
reporting the antioxidant capability of several micronu-
trients that, accordingly, are regarded as potent antioxi-
dants. It has been reported that folates effectively
scavenge oxidizing free radicals by inhibiting lipid perox-
idation [34], thus playing a key role in oocyte quality
and maturation [35]. In this regard, poor folate status
seems to be detrimental also due to its involvement in cell
division (e.g. of oogonia and/or granulosa cells), inflamma-
tory cytokine production and defective methylation reac-
tions [38]. The latter, in turn, are the main regulators of
DNA synthesis, a pivotal process in oocytes development.
It has been reported that several enzymes involved in
DNA synthesis are vitamin- or zinc-dependent [39]. Zinc
might also affect female fertility due to its antioxidant
properties: in fact, zinc can counteract the oxidation by
binding sulphydryl groups in proteins and by occupying
binding sites for iron and copper in lipids, proteins and
DNA [40, 41]. In this regard, the supplementation of a
chelated form of zinc may contribute to the reduction of
oxidative stress, while retaining safety since assumed at
dose far below the tolerable upper level of 40 mg/day.
Also the potential toxicity of cationes, such as iron
and calcium, is hindered by their low dose. Moreover,
it is remarkable that women with normal menstrual
cycles could have deficiency of such compounds. An
influence of these mineral on oocyte development and
fertilization process has been highlighted. It has been
reported that the consumption of iron supplements
and non-heme iron from foods may decrease the risk
of ovulatory infertility [41], and that oxidative stress
in unfertilized mouse oocytes induces abnormal cal-
cium oscillation [42].
Fig. 2 Avidin-blotting after two dimensional electrophoresis of biotin-labeled free-SH residues in serum (a, b) and follicular fluid (c, d) from
untreated patient (a, c) or patient treated with micronutrients supplementation (b, d). The values are the mean ± SD. Statistically significant difference
in relative intensity is indicated (*P < 0.05)
Table 2 Oocyte maturity and embryo score in the same
patients who didn’t received (Untreated) or received (Treated)
micronutrients supplementation form three months
Characteristic Untreated Treated P value
No. of retrieved oocytes 6.76 ± 4.12 6.37 ± 3.31 NS
No. of MII oocytes 5.14 ± 3.49 4.07 ± 3.04 NS
No. of not suitable oocytes (GV-DEG) 1.88 ± 1.01 1.2 ± 0.77 0.01
Fertilization rate 0.69 ± 0,15 0.71 ± 0,28 NS
Cleavage rate 0.84 ± 0.04 0.85 ± 0.07 NS
No. of embryos transfered 2.01 ± 0.55 1.96 ± 0.75 NS
Embryo score grade 1 (%) 0.96 ± 0.5 0.91 ± 0.45 NS
Embryo score grade 2 (%) 0.87 ± 0.75 0.84 ± 0.71 NS
Embryo score grade 3 (%) 0.29 ± 0.64 0.30 ± 0.5 NS
Note: Values are mean ± SD. The embryos were scored according to the criteria
established by Ebner et al. [27]. DEG degenerated occytes, MII metaphase II, NS
not significant; GV germinal vesicle
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Also vitamins seems to play a key role in oocyte mat-
uration, since their deficiencies have been linked to a di-
minished fertility in animals [43]. In a recent study, we
have demonstrated that vitamin receptor VDR/RXR-α
(vitamin D receptor and retinoid X receptor-alpha het-
erodimer) are involved in follicular fluid homeostasis,
suggesting the existence of a close functional correlation
among follicular protein and micronutrients [44]. VDR
has been hypothesized to control several human genes,
thus vitamin D aberrant endogenous production or diet-
ary up-take may severely affect the follicular physiology
[42]. Vitamin D supplementation has been recently dem-
onstrated to increase the serum soluble form of Recep-
tor for Advanced Glycation End-products (sRAGE) [45].
sRAGE was also detected in HFF and its incremented
concentration has been associated to positive IVF out-
comes [46, 47]. These soluble receptors exert a “scaven-
ger” activity of advanced glycation end-products (AGEs),
potent pro-inflammatory molecules that cause ROSgen-
eration. The AGE/sRAGE interaction, by preventing the
binding of AGE to cellular receptor (cRAGE), counterbal-
ances the well known detrimental effects of AGE [48]. In
summary, by inducing the expression of sRAGE through
VDR/RXR-α, vitamin D may modulate AGE/RAGE-sys-
tem, thus diminishing follicular fluid oxidative stress.
Vitamin E has been reported as a scavenger of lipid
peroxyl radicals and suppresses the generation of lipid
hydroperoxides from cell membrane phospholipids, by
acting synergistically with other antioxidant nutrients in-
cluding vitamin C, carotene, melatonin and selenium
[23]. The latter is reported to act both as an antioxidant
and anti-inflammatory mediator. The antioxidant activity
is achieved by the reduction of lipid and hydrogen perox-
ides, thus lowering free radicals and ROS spreading. More-
over, selenium supplementation plays a pivotal role in
regulating thyroid function by improving the conversion
of plasma thyroxine (T4) into the active hormone, T3 [49].
Our data suggest that the appropriate administration
of these micronutrientss may therefore have significant
effects on redox status of follicular microenvironment
and, ultimately, on IVF outcome.
The evidence that oocyte maturation, ovulation, luteo-
lysis and follicle atresia are affected by ROS unbalance
along with the demonstration that the oxidative stress
might be influenced by micronutrients intake, supports
our results reporting the effectiveness of this micronutri-
ents supplementation also in term of oocyte quality. To
our knowledge, only limited information is available on
the impact of dietary micronutrients supplementation
on IVF outcome.
Conclusion
In conclusion, the biochemical evaluations carried out in the
present preliminary study points out that a micronutrients
supplementation may decreases oxidative stress both in
serum and in follicular fluid proteins and it is positively
associated with oocytes quality. These information may be
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